Technical Analysis for CGIX - Cancer Genetics, Inc.

Grade Last Price % Change Price Change
grade F 0.205 -2.38% -0.01
CGIX closed down 2.38 percent on Monday, May 20, 2019, on 65 percent of normal volume. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical CGIX trend table...

Date Alert Name Type % Chg
Spinning Top Other 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness -2.38%
Lower Bollinger Band Touch Weakness -2.38%
Oversold Stochastic Weakness -2.38%
Stochastic Buy Signal Bullish -2.19%
Lower Bollinger Band Walk Weakness -2.19%

Older signals for CGIX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Cancer Genetics, Inc., an early-stage diagnostics company, focuses on the development and commercialization of proprietary genomic tests and services to improve and personalize the diagnosis, prognosis, and response to treatment of cancer. The company offers a range of services in various areas, including microarray based testing, a proprietary microarray test for the detection of chromosomal abnormalities observed in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma and Diffuse Large B-cell Lymphoma; molecular testing to analyze DNA and RNA to follow progression of disease and response to therapy at the genetic level; cytogenetics testing, a series of methods for analyzing human chromosomes to identify malignancy; fish testing, an analysis of abnormalities at the chromosomal and gene levels; flow cytometry testing, an immuno pheno - type analysis of specific markers inside cells; histology testing, a microscopic examination of stained tissue sections; cytology testing, a non-gynecological fluid preparation for microscopic evaluations by a pathologist; and IHC testing, an analysis of the distribution of tumor antigens in specific cell and tissue types. It offers DNA-based cancer diagnostics and services medical institutions. The company's tests target cancers, including hematological, urogenital, and HPV-associated cancers. It also provides a range of non-proprietary oncology-focused tests and laboratory services that offer critical genomic information to healthcare professionals, as well as biopharma and biotech. The company was founded in 1999 and is headquartered in Rutherford, New Jersey.
Cancer Biology Disease Treatment Of Cancer Cancers Molecular Biology Tumor Lymphoma Healthcare Professionals Chronic Lymphocytic Leukemia Anatomical Pathology Laboratory Services Human Papillomavirus Infection Cytogenetics Dna Chip Fluorescence In Situ Hybridization
Is CGIX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.3
52 Week Low 0.195
Average Volume 1,571,236
200-Day Moving Average 0.513
50-Day Moving Average 0.243
20-Day Moving Average 0.2242
10-Day Moving Average 0.2176
Average True Range 0.023
ADX 17.72
+DI 15.3321
-DI 16.0149
Chandelier Exit (Long, 3 ATRs ) 0.226
Chandelier Exit (Short, 3 ATRs ) 0.264
Upper Bollinger Band 0.251
Lower Bollinger Band 0.1974
Percent B (%b) 0.14
BandWidth 23.907226
MACD Line -0.0106
MACD Signal Line -0.009
MACD Histogram -0.0016
Fundamentals Value
Market Cap 4.06 Million
Num Shares 19.8 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 1.94
Price-to-Book 2.87
PEG Ratio -0.08
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.23
Resistance 3 (R3) 0.23 0.22 0.23
Resistance 2 (R2) 0.22 0.21 0.22 0.22
Resistance 1 (R1) 0.21 0.21 0.22 0.21 0.22
Pivot Point 0.20 0.20 0.21 0.20 0.20
Support 1 (S1) 0.20 0.20 0.20 0.20 0.19
Support 2 (S2) 0.19 0.19 0.19 0.19
Support 3 (S3) 0.18 0.19 0.18
Support 4 (S4) 0.18